In this pilot study, the investigators aim to assess feasibility of subject identification
and data collection, including specimen processing, as well as the rate of enrollment for a
future, larger study of the effect of empiric antibiotics for all patients with advanced
cirrhosis admitted to the hospital without an existing indication for new antibiotic use.
Specifically, the investigators will assess the incidence of infection after the time of
enrollment and associated outcomes. Subjects will be randomly assigned to receive antibiotics
vs placebo.
Phase:
Phase 4
Details
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborator:
American Association for the Study of Liver Diseases Foundation